Physician

General Surgery

Ronald Mattson practices General Surgery. He attended Temple University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification", "Super Doctor", "Top MD" and "Fellow (FACS)". Doctor Ronald J. Mattson, MD is also published. He has 31 publications published. The lastest publication: "In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.' Ronald Mattson is registered with Medicare and accepts Medicare payments.

Publications

---

• Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
• Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
• Potential CRF1R PET imaging agents: 1-Fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.
• Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
• A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5...
• In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
• Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
• Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
• Catalytic asymmetric diazoacetate cyclopropanation of 1-tosyl-3-vinylindoles. A route to conformationally restricted homotryptamines.
• Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.
• Surgical approach to anterior scalenectomy.
• Evaluation of 99mTc-labeled iminodiacetic acid derivatives of substituted 2-aminopyrroles as hepatobiliary imaging agents in rats II.
• Evaluation of 99mTc-labeled iminodiacetic acid derivatives of substituted 2-aminopyrroles as hepatobiliary imaging agents. I.
• Synthesis of alkylaminoalkylamides of substituted 2-aminopyrroles as potential local anesthetic and antiarrhythmic agents I: alpha-Amines.
• [3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain.
• In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.
• Enantioselective synthesis of a highly potent selective serotonin reuptake inhibitor. An application of imidazolidinone catalysis to the alkylation of indoles with an ...
• Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides.
• Ligand conformation has a definitive effect on 5-HT1A and serotonin reuptake affinity.
• Diaminopyrimidine and diaminopyridine 5-HT7 ligands.
• Aminotriazine 5-HT7 antagonists.
• Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
• Indanyl piperazines as melatonergic MT2 selective agents.
• Development of a presynaptic 5-HT1A antagonist.
• Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).
• Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl Analogs of a potent selective serotonin reuptake inhibitor.
• Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
• Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
• Synthesis and hSERT activity of homotryptamine Analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.
• Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.

Schools

---

• Temple University School Of Medicine

• Bryn Mawr Hospital

Procedures Preformed

---

• Arteriovenous Shunt Creation
• Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
• Embolectomy, Thrombectomy, or Vessel Exploration
• Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
• View All

Conditions Treated

---

• Abdominal Pain
• Anal and Rectal Cancer
• Atelectasis
• Breast Cancer
• View All

Doctors Specialties

---

• General Surgery

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Super Doctor
• Top MD
• Fellow (FACS)

Education

---

• Temple University School of Medicine

Drug Facts

---

NPI NUMBER		1851351910
NPPES Provider LastName		MATTSON
NPPES Provider FirstName		RONALD
NPPES Provider ZIPCode		19010
NPPES Provider State		PA
Specialty Description		Vascular Surgery
Total Claim Count		128.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1851351910
Last Name Of The Provider	MATTSON
First Name Of The Provider	RONALD
View All

Similar Doctors

---

	Dr. Philip Y. Pearson, MD This Doctor is OpenDoctor Recommended.
	Dr. Kinzie A. Matlock, MD
	Dr. Khuzema Kanchwala, MD
	Dr. Muhammad Golsorkhi, MD This Doctor is OpenDoctor Recommended.
	Dr. George A. Trajtenberg, MD
	Dr. Piotr Krecioch, MD This Doctor is OpenDoctor Recommended.
	Dr. Derek M. Guirand, MD
	Dr. David M. Rose, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard D. Ing, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas G. Frazier, MD This Doctor is OpenDoctor Recommended.
	Dr. Roslyn C. Souser, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert B. Noone Sr., MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer L. Denne, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrea V. Barrio, MD This Doctor is OpenDoctor Recommended.
	Dr. Chris D. Tzarnas, MD
	Dr. Steven R. Growney, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog